Equioxx
Active substance
ATC code
Species
Horses (450–600 kg)
Indications
Alleviation of pain and inflammation associated with osteoarthritis and reduction of associated lameness in horses.
Dose to be administered and administration route
Oral use.
Administer one tablet once daily for horses weighing 450–600 kg bodyweight.
Duration of treatment will be dependent on the response observed, but should not exceed 14 days.
One tablet should be administered with a small amount of food in a bucket or direct by hand, presenting the tablet combined with a small amount of food or with a treat in the palm of the hand. After administration, it is recommended to examine the buccal cavity to ensure that the tablet has been adequately swallowed.
Adverse reactions
Lesions (erosion/ulceration) of the oral mucosa and of the skin around the mouth were very commonly observed in treated animals during tolerance studies. These lesions were mild and resolved without treatment. Salivation and labial and tongue oedema have been uncommonly associated with the oral lesions in a field study.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals, including isolated reports treated)
Similar products
Showing 1 of 1 results
